PKC β pseudosubstrate TFA, a biomedical marvel, emerges as an impeccable remedy boasting transformative potential for a plethora of maladies affiliated with protein kinase C (PKC) β. Functioning as an extraordinary pseudosubstrate, this phenomenal innovation proficiently curtails the robust activity of PKC β. A veritable panacea, this cutting-edge product propels unrivaled advancements in therapeutic protocols by precisely combating PKC β-associated afflictions such as malignant neoplasms, inflammatory reactions, and cardiovascular anomalies.
CAT# | GR2225 |
M.F/Formula | C179H295F3N62O40S3 |
M.W/Mr. | 4108.84 |
* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).
Creative Peptides has accumulated a huge library of peptide knowledge including frontier peptide articles, application of peptides, useful tools, and more!
Background Signal peptides stimulate matrix protein production in general and collagen synthesis in specific. They may be acc ...
GsMTx4 is a synthetic and biologically active peptide toxin. Its molecular formula is C185H273N49O45S6, with the ...
Huwentoxin IV, a 35-amino-acid-residue polypeptide from Chinese tarantula Ornithoctonus huwena venom, is a kind ...
BIO 1211, is a non-covalent, small-molecule, cyclohexanecarboxylic acid base compound, tight-binding inhibitor ( ...
Aviptadil acetate, the nonproprietary or generic name for a vasoactive intestinal peptide (VIP), is a synthetic ...